Autoantibody production and cytokine profiles of MHC class I (β2- microglobulin) gene deleted New Zealand Black (NZB) mice

Clinical Immunology and Immunopathology

Volumn 84, Issue 3, 1997, Pages 318-327

  Chen, Shao Yuan ^a   Takeoka, Yuichi ^a,d   Pike Nobile, Larry ^a   Ansari, Aftab A ^b   Boyd, Richard ^c   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MONASH UNIVERSITY   (Australia)

^d Nippon Zoki Pharmaceutical Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA 2 MICROGLOBULIN; CYTOKINE; DNA ANTIBODY; DOUBLE STRANDED DNA; ERYTHROCYTE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SINGLE STRANDED DNA;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; GENE DELETION; LUPUS ERYTHEMATOSUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS;

EID: 0031239980     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4398     Document Type: Article

References (42)

1. Shores E. W., Van Ewijk W., Singer A. Disorganization and restoration of thymic medullary epithelial cells in T cell receptor-negative scid mice: Evidence that receptor-bearing lymphocytes influence maturation of the thymic microenvironment. Eur. J. Immunol. 21:1991;1657-1661.
2. Brekelmans P., Van Ewijk W. Phenotypic characterization of murine thymic microenvironments. Semin. Immunol. 2:1990;13-24.
3. Van Ewijk W. T cell differentiation is influenced by thymic microenvironments. Annu. Rev. Immunol. 9:1991;591-615.
4. Van Ewijk W., Shores E. W., Singer A. Crosstalk in the mouse thymus. Immunol. Today. 15:1994;214-217.
5. Weissman I. L. Developmental switches in the immune system. Cell. 76:1994;207-218.
6. ++. J. Exp. Med. 179:1994;2027-2031.
7. Chen S.-Y., Takeoka Y., Ansari A. A., Boyd R., Klinman D. M., Gershwin M. E. The natural history of disease expression in CD-4 and CD-8 gene deleted New Zealand Black (NZB) mice. J. Immunol. 157:1996;2676-2684.
8. +. Science. 248:1990;1227-1230.
9. +. Nature. 344:1990;742-746.
10. Gershwin M. E., Castles J. J., Erickson K., Ahmed A. Studies of congenitally immunologic mutant New Zealand mice. II. Absence of T cell progenitor populations and B cell defects of congenitally athymic (nude) New Zealand Black (NZB) mice. J. Immunol. 122:1979;2020-2025.
11. Gershwin M. E., Castles J. J., Ikeda R. M., Erickson K., Montero J. Studies of congenitally immunologic mutant New Zealand mice. I. Autoimmune features of hereditarily asplenic (Dh/+) NZB mice: Reduction of naturally occurring thymocytotoxic antibody and normal suppressor function. J. Immunol. 122:1979;710-717.
12. Godfrey D. I., Izon D. J., Tucek C. L., Wilson T. J., Boyd R. L. The phenotypic heterogeneity of mouse thymic stromal cells. Immunology. 70:1990;66-74.
13. Wood G. S., Warnke R. A. The immunologic phenotyping of bone marrow biopsies and aspirates: Frozen section techniques. Blood. 59:1982;913-922.
14. Watanabe Y., Naiki M., Wilson T., Godfrey D., Chiang B. L., Boyd R., Ansari A., Gershwin M. E. Thymic microenvironmental abnormalities and thymic selection in NZB.H-2bm12 mice. J. Immunol. 150:1993;4702-4712.
15. Ohsugi Y., Gershwin M. E., Ahmed A., Skelly R. R., Milich D. R. Studies of congenitally immunologic mutant New Zealand mice. VI. Spontaneous and induced autoantibodies to red cells and DNA occur in New Zealand X-linked immunodeficient (Xid) mice without phenotypic alternations of the Xid gene or generalized polyclonal B cell activation. J. Immunol. 128:1982;2220-2227.
16. Kisielow P., Teh H. S., Bluthmann H., von Boehmer H. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature. 335:1988;730-733.
17. Teh H. S., Kisielow P., Scott B., Kishi H., Uematsu Y., Bluthmann H., von Boehmer H. Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature. 335:1988;229-233.
18. Yewdell J. W., Bennink J. R. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1992;1-123.
19. Bix M., Raulet D. Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells. J. Exp. Med. 176:1992;829-834.
20. Udaka K., Marusic-Galesic S., Walden P. CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression. J. Immunol. 153:1994;2843-2850.
21. Glas R., Ohlen C., Hoglund P., Karre K. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I. J. Exp. Med. 179:1994;661-672.
22. Zijlstra M., Auchincloss H. Jr., Loring J. M., Chase C. M., Russell P. S., Jaenisch R. Skin graft rejection by beta 2-microglobulin-deficient mice. J. Exp. Med. 175:1992;885-893.
23. Marusic-Galesic S., Udaka K., Walden P. Increased number of cytotoxic T cells within CD4+8- T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice. Eur. J. Immunol. 23:1993;3115-3119.
24. Burnet F. M. A reassessment of the forbidden clone hypothesis of autoimmune disease. Aust. J. Exp. Biol. Med. Sci. 50:1972;1-9.
25. Hartwell D., Levine J., Fenton M., Francis C., Leslie C., Beller D. Cytokine dysregulation and the initiation of systemic autoimmunity. Immunol. Lett. 43:1994;15-21.
26. Wofsy D. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. J. Immunol. 136:1986;4554-4560.
27. Wofsy D., Seaman W. E. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:1985;378-391.
28. Santoro T. J., Portanova J. P., Kotzin B. L. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J. Exp. Med. 167:1988;1713-1718.
29. Adelman N. E., Watling D. L., McDevitt H. O. Treatment of (NZB × NZW)F1 disease with anti-I-A monoclonal antibodies. J. Exp. Med. 158:1983;1350-1355.
30. Datta S. K., Mohan C., Desai-Mehta A. Mechanisms of the pathogenic autoimmune response in lupus: prospects for specific immunotherapy. Immunol. Res. 14:1995;132-147.
31. Yao Z., Seelig H. P., Ehrfeld H., Renz M., Hartung K., Deicher H., Keller E., Nevinny-Stickel C., Albert E. D. HLA class II genes and antibodies against recombinant U1-nRNP proteins in patients with systemic lupus erythematosus. SLE Study Group. Rheumatol. Int. 14:1994;63-69.
32. Fujiura Y., Kawaguchi M., Kondo Y., Obana S., Yamamoto H., Nanno M., Ishikawa H. Development of CD8 alpha alpha+ intestinal intraepithelial T cells in beta 2-microglobulin- and/or TAP1-deficient mice. J. Immunol. 156:1996;2710-2715.
33. Apasov S., Sitkovsky M. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice. Proc. Natl. Acad. Sci. USA. 90:1993;2837-2841.
34. Apasov S. G., Sitkovsky M. V. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells. J. Immunol. 152:1994;2087-2097.
35. Lamouse-Smith E., Clements V. K., Ostrand-Rosenberg S. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection. J. Immunol. 151:1993;6283-6290.
36. Ljunggren H.-G., Glas R., Sandberg J. K., Karre K. Reactivity and specificity of CD8+ T cells in mice with defects in the MHC class I antigen-presenting pathway. Immunol. Rev. 151:1996;123-148.
37. Mozes E., Kohn L. D., Hakim F., Singer D. S. Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science. 261:1993;91-93.
38. Bendelac A. Mouse NK1+ T cells. Curr. Opin. Immunol. 7:1995;367-374.
39. MacDonald H. R. NK1.1+ T cell receptor-alpha/beta+ cells: New clues to their origin, specificity, and function. J. Exp. Med. 182:1995;633-638.
40. Yoshimoto T., Paul W. E. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1994;1285-1285.
41. Malnati M. S., Peruzzi M., Parker K. C., Biddison W. E., Ciccone E., Moretta A., Long E. O. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science. 267:1995;1016-1018.
42. Spriggs M. K., Koller B. H., Sato T., Morrissey P. J., Fanslow W. C., Smithies O., Voice R. F., Widmer M. B., Maliszewski C. R. Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc. Natl. Acad. Sci. USA. 89:1992;6070-6074.